This smart pill will tattle to your doctor if you don’t take your meds

By Luke Dormehl Published April 2, 2019

Image used with permission by copyright holder

Have you ever been prescribed medication and then forgotten to take a dose and accidentally skipped it? It’s one thing if that’s a drug designed to treat a minor skin infection. But what if it’s something far more life-altering, like an antiretroviral drug used for treating HIV? In that case, defaulting on said drug could be profoundly dangerous. At the very least, it’s something your family physician would probably want to know about it.

Thanks to a new kind of smart pill, called ID-Cap, they very soon will be able to. Developed by the medical startup EtectRx, ID-Cap is an ingestible capsule and sensor system which can reveal when it’s been successfully taken by a patient. “There is well-documented medical research that patients are not as good as they should be as at taking their medicine; this is known as being non-adherent,” Harry Travis, president and CEO of EtectRx, told Digital Trends. “We believe our technology will, in some small way, help clinicians help their patients take their medicine.”

Recommended Videos

The system is comprised of three parts: the ID-Capsule, ID-Tag, and ID-Cap Reader, alongside a software layer which allows the data to be displayed for both patient and clinician. The ID-Capsule is a standard pharmaceutical capsule shell containing the ID-Tag ingestible sensor. This sensor emits a very low power radio frequency digital message from within the patient, which is sent to the ID-Cap Reader, a wearable device that verifies the message as a valid ingestion event. Finally, the information is transmitted, via Bluetooth LE, to data display systems utilized by clinicians and patients.

EtectRx is currently waiting for official clearance from the U.S. Food and Drug Administration (FDA). It hopes that this will be granted later this year. It is also the subject of a study being carried out in partnership with Brigham and Women’s Hospital in Boston and the Fenway Institute at Fenway Health.

This study will examine what impact the system could have on patients potentially adhering to HIV medication. That is crucial for reasons which go way beyond simply one patient. When it comes to a potentially deadly disease like HIV, being able to ensure that antiretrovirals are taken could help end the spread of HIV. What more could you want from a smart pill?

Former Contributor

I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…

Topics

Emerging Tech

ChatGPT Pro replaced Gemini Notebook as my favorite research app, and I didn’t see it coming

Electronics, Phone, Mobile Phone

I've been using Gemini Notebook ever since it launched, and for the longest time, it was my go-to app for just about everything. Whether I was researching a topic, organizing work, or studying something new, it became one of those apps I instinctively opened without thinking. When Google kept adding new features, I genuinely believed it had secured a permanent spot in my workflow.

Then, almost without realizing it, ChatGPT Pro took over. I've been using its Work mode for a while now, and somewhere along the way, it replaced Gemini Notebook. Of course, it wasn't an overnight switch. I kept bouncing between the two for weeks, but I gradually found myself reaching for ChatGPT every single time instead. At some point, I realized I hadn't opened Gemini Notebook in days. Now, I honestly don't use it at all.

Emerging Tech

AI chatbots will happily create fake news articles, and tests show ChatGPT is the worst at it

Electronics, Phone, Mobile Phone

The biggest AI chatbots are supposed to help people find information, not manufacture misinformation. But a new investigation suggests that separating those two jobs isn't as straightforward as many AI companies would like users to believe. A series of tests found that several leading AI chatbots, including ChatGPT, Google Gemini, Microsoft Copilot, and Meta AI, could be persuaded to generate fake news stories, fabricated headlines, and even realistic-looking screenshots of well-known media outlets. While every chatbot showed some weaknesses, ChatGPT reportedly performed the worst, producing the most convincing fake content with surprisingly little effort.

The findings come from an investigation by German newsroom CORRECTIV, which tested how the AI assistants responded when asked to create false reports involving sensitive topics such as election fraud, government coups, war, vaccines, climate change, and conspiracy theories.

Emerging Tech

DeepSeek just slashed AI prices again, and China’s AI race is getting even messier

DeepSeek AI chatbot running on an iPhone.

China's AI race has never really been short on competition, but it's increasingly looking like a battle over who can charge the least rather than who can build the best model.

DeepSeek has unveiled its latest open-weight AI model, called V4-Flash, alongside a dramatic price reduction that makes it significantly cheaper for developers to use. The company has cut token pricing by 50% and has also decided against introducing a previously announced dynamic pricing system that would have increased costs during periods of heavy demand. The new changes paint a clear picture: DeepSeek appears more interested in winning over developers and expanding its user base than maximizing revenue in the short term.